Stay updated on Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal regarding the study of Sitravatinib for advanced liposarcoma, including details about the study's purpose, treatment criteria, and patient eligibility. The only notable addition is the mention of the revision number and collaborators.SummaryDifference44%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.